SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001064901-08-000001
Filing Date
2008-08-14
Accepted
2008-08-14 21:13:54
Documents
1
Period of Report
2008-06-30

Document Format Files

Seq Description Document Type Size
1 inb5_christinakayex.html 5  
1 inb5_christinakayex.xml 5 21176
  Complete submission text file 0001064901-08-000001.txt   23093
Mailing Address 201 ROUTE 22 HILLSIDE NJ 07205
Business Address 201 ROUTE 22 HILLSIDE NJ 07205 9739260816
INTEGRATED BIOPHARMA INC (Issuer) CIK: 0001016504 (see all company filings)

IRS No.: 133035216 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address 201 ROUTE 22 HILLSIDE NJ 07205 9739260816
KAY CHRISTINA (Reporting) CIK: 0001064901 (see all company filings)

Type: 5 | Act: 34 | File No.: 001-31668 | Film No.: 081021143